search
Back to results

Understanding Public Attitudes Towards the COVID-19 Vaccination (CEAL)

Primary Purpose

Covid19, Vaccination

Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Communication about the COVID-19 vaccination from the Massachusetts Department of Public Health
Sponsored by
University of Massachusetts, Worcester
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Covid19

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Massachusetts resident
  • Adult (age 18 and over)
  • English or Spanish speaking

Exclusion Criteria:

• Non-English or Spanish speaking

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Experimental

    Arm Label

    Message 1

    Message 2

    Arm Description

    Participants will be randomized to receive version #1 of 2 different versions of a message from the Massachusetts Department of Public Health regarding the COVID-19 vaccination.

    Participants will be randomized to receive version #2 of 2 different versions of a message from the Massachusetts Department of Public Health regarding the COVID-19 vaccination.

    Outcomes

    Primary Outcome Measures

    Intent to be vaccinated against Covid-19 among unvaccinated participants
    The survey includes a question that assesses participants' willingness to be vaccinated against Covid-19 if they are unvaccinated. Responses include Yes, No, or Not Sure to being vaccinated against Covid-19.

    Secondary Outcome Measures

    Full Information

    First Posted
    August 24, 2021
    Last Updated
    June 2, 2022
    Sponsor
    University of Massachusetts, Worcester
    Collaborators
    Boston University, National Heart, Lung, and Blood Institute (NHLBI)
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05023512
    Brief Title
    Understanding Public Attitudes Towards the COVID-19 Vaccination
    Acronym
    CEAL
    Official Title
    Together Researching Understanding, Solidarity, and Trust Around COVID - TRUST Study
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    June 2022
    Overall Recruitment Status
    Withdrawn
    Why Stopped
    This study is not a clinical trial.
    Study Start Date
    October 28, 2021 (Actual)
    Primary Completion Date
    July 15, 2022 (Anticipated)
    Study Completion Date
    September 1, 2022 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    University of Massachusetts, Worcester
    Collaborators
    Boston University, National Heart, Lung, and Blood Institute (NHLBI)

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The objective of this study is to better understand public attitudes towards coronavirus disease 2019 (COVID-19) vaccination. This understanding will inform the development of community engagement strategies to be used in future interventions and studies aimed at addressing factors that impact the disproportionate burden of COVID-19 in under-served and vulnerable communities.
    Detailed Description
    The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly instigated a global pandemic. As of this writing, there are more than 33 million documented cases of infection in the United States (US). Furthermore, in the US, COVID-19 has disrupted the economy, overwhelmed the healthcare system, led to widespread school cancellations, and caused more than 595,000 deaths since March 2020. The availability of three highly effective vaccines against COVID-19 within a year of the start of the pandemic is an extraordinary achievement and cause for great optimism. However, a significant proportion of adults in the U.S. have not accepted vaccination against COVID-19. Efforts are needed to identify effective messages and communication strategies to overcome COVID-19 vaccine hesitancy. To address this need, the investigators plan to conduct two rapid surveys among Massachusetts residents, to assess attitudes towards COVID-19 vaccination.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Covid19, Vaccination

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Factorial Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    0 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Message 1
    Arm Type
    Experimental
    Arm Description
    Participants will be randomized to receive version #1 of 2 different versions of a message from the Massachusetts Department of Public Health regarding the COVID-19 vaccination.
    Arm Title
    Message 2
    Arm Type
    Experimental
    Arm Description
    Participants will be randomized to receive version #2 of 2 different versions of a message from the Massachusetts Department of Public Health regarding the COVID-19 vaccination.
    Intervention Type
    Behavioral
    Intervention Name(s)
    Communication about the COVID-19 vaccination from the Massachusetts Department of Public Health
    Intervention Description
    Participants will be randomized to receive one of two different versions of messages from the Massachusetts Department of Public Health. The message that participants in each experimental group receive will vary slightly and systematically. Specific content and wording of these messages were developed to address and mitigate concerns about the Covid-19 vaccination.
    Primary Outcome Measure Information:
    Title
    Intent to be vaccinated against Covid-19 among unvaccinated participants
    Description
    The survey includes a question that assesses participants' willingness to be vaccinated against Covid-19 if they are unvaccinated. Responses include Yes, No, or Not Sure to being vaccinated against Covid-19.
    Time Frame
    Through survey completion, an average of 12 minutes

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Massachusetts resident Adult (age 18 and over) English or Spanish speaking Exclusion Criteria: • Non-English or Spanish speaking
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Kimberly Fisher, MD
    Organizational Affiliation
    University of Massachusetts, Worcester
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Understanding Public Attitudes Towards the COVID-19 Vaccination

    We'll reach out to this number within 24 hrs